Navigation Links
New Vaccine Targeted At Effective Treatment Against Tuberculosis

Globally, tuberculosis remains the number one killer in adults. TB is a lung disease, caused by a bacterium. Health experts say a new person is infected with TB somewhere in the world every second. //

A vaccine against tuberculosis, termed BCG is currently available which, however, fails to protect against the most frequent form of disease, pulmonary tuberculosis in adults. Moreover, multi-drug-resistant tuberculosis strains are on the rise, which cannot be treated by first-line drugs. A more efficient vaccine is urgently needed for control of this global threat.

A new vaccine has now been developed with the hope of helping combat the disease better and the efficacy will be tested in the 2006 clinical trials.

The recombinant vaccine has been shown to stimulate far more efficacious protection against tuberculosis than the BCG vaccine currently in use. This new vaccine induces cell death in the infected host cells; as a result, stronger protection against pulmonary tuberculosis has been achieved in preclinical studies.

Importantly, the new vaccine also protects against a special form of tuberculosis that are multi-drug resistant and more aggressive. It has been assumed that the new form of the organism has emerged in response to drug treatment and vaccination. The new genetically engineered BCG could provide a challenge against this threat.
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
(Date:10/10/2008)...More than 600 new Wisconsin,voters can participate...e,result of Aurora Health Care,s voter registratio...ealth care system,s 13 hospitals across Eastern,Wi...t the drives., Aurora employees and volunteers, w...tability Board to serve as special registration de...
(Date:10/10/2008)...nt for behavior change, DES MOINES, Iowa, Oct. 10...cans (51 percent) believe there are good things ab...ges are needed, according to the 2008,EBRI Health ...y the,Employee Benefit Research Institute and Math...tten by the Principal Financial Group(R)., To vie...
(Date:10/10/2008)...NuView Life Sciences Inc.,(NuView) has agreed to a...e), including operations of the linear accelerator...xas. The Trace facility produces,Copper-64, Copper... in,molecular imaging and nuclear medicine. Paul C... confident that by improving operational,efficienc...
(Date:10/10/2008)...wire/ -- Public interest,advocates(1) welcomed the...sions on the threats posed by mercury to human hea... UNEP(2) Open Ended Working Group (OEWG2) on,Mercu...a global framework,on mercury, in preparation for ...where it will be decided whether a global legally-...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Elements for a UN Global Framework on Mercury Agreed to 2
...re most likely to gain weight, a new study says//....n 2,300 girls aged nine and 10 and followed them f...height, weight, blood pressure and cholesterol eve...n had the teens report their own measures at ages ...
...y became the first in the country to win a new gov... quality patient care. The National Accreditation...(NABH) certification "is an endorsement of our foc..., the hospital's chief operating officer, told IAN...
...ily of enzymes called sirtuins, which can dramatic...t, worms, and flies. Now, a new study from scient...ategy for activating sirtuins to unleash their ant...to control age-associated metabolic disorders, inc...
...e marijuana is not easy as it results in withdrawa...ly in life the usage started. Marijuana, a mixtur... plant, Cannabis sativa, is smoked as a cigarette ...annabinol) is the main active chemical present in ...
Other Medicine News:Health News:Adolescent Girls More Likely to Gain Weight: Study 2Health News:Anti-Aging Powers of Enzyme Sirtuins 2
(Date:10/8/2008)...mab Program to be Discontinued and Headcount to be... its Portfolio Review; Zanolimumab Program to be ...r of Employees, COP...b A/S (OMX: GEN),announced today that it is discon... In addition, as a result of a portfolio review an...
(Date:10/8/2008)... program to evaluate TAXUS(R) Element(TM) Platinum...NATICK, Mass., Oct. 8 /- Bo...nounced that it has completed enrollment in,the PE...ird-generation,TAXUS(R) Element(TM) paclitaxel-elu...has enrolled nearly 1,500 patients at 100 U.S. and...
(Date:10/8/2008)..., Oct. 8 /- Vical Incorporated (Nasda...ata and new nonclinical data,demonstrating that th...pplicable in DNA- and protein-based infectious dis...lain P. Rolland, Pharm.D., Ph.D., Vical,s,Senior V... the data today,Wednesday, October 8, at the Worl...
(Date:10/7/2008)...ct. 7 /- Prometheus Laboratories Inc....ced findings from its,development of PROMETHEUS(R)... irritable bowel syndrome (IBS). The findings sugg...rticular biomarkers in blood samples,between IBS a...iomarkers,combined with a proprietary algorithm, ...
Breaking Medicine Technology:Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Ultrasonic frogs can tune their ears to different frequencies 4146 1Ultrasonic frogs can tune their ears to different frequencies 4146 2Ultrasonic frogs can tune their ears to different frequencies 4146 3Insmed CEO to Present at Congressional Briefing on Follow On Biologics 2682 1Insmed CEO to Present at Congressional Briefing on Follow On Biologics 2682 2Insmed CEO to Present at Congressional Briefing on Follow On Biologics 2682 3Cynosure Receives CE Mark for Smartlipo MPX 28TM 29 Workstation 2678 1Cynosure Receives CE Mark for Smartlipo MPX 28TM 29 Workstation 2678 2Cynosure Receives CE Mark for Smartlipo MPX 28TM 29 Workstation 2678 3Minimally Invasive Treatment Improves Male Fertility 24257 1Minimally Invasive Treatment Improves Male Fertility 24257 2Minimally Invasive Treatment Improves Male Fertility 24257 3
...s, Ace393, the World,s First Commercial Vaccine,fo...ccessfully,Completes Phase I Clinical Trials , ,Tr...genicity , ODENSE, Denmark, March 28, 2007 -ACE Bi...pleased to announce the successful,completion of P...93, the world,s first commercial vaccine for Trave...
...ions Reached in Key Lung Compartments, REINACH and...rstCall/ -- Arpida Ltd. today announced promising,...se radiolabelled,Human Microdose studies included ...ndbreaking study is the first ever using Microdosi... lung compartments.,The results showed that AR-709...
Other Medicine Technology:Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 2Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 3Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5
Unshielded
...s an advanced multi-modality system. The Easy II P...32-channel digital EEG amplifier with seven active... like airflow, respiratory effort and snoring. The...s, a built-in pulse oximeter, and a body position ...
...b Salvage System offers five different products fo... these components are cobalt-chrome, ultra high mo...RDIAN products are extensions of Wright Medical Te...s. , ,The distal femur consists of a rotating hin...
...m features 270 accessibility and the most compact,... diameter available (54 inches). Multichannel imag...r coils, increased patient comfort, and shorter ex...a. , ,The Magnetom C! comes equipped with work...
Medicine Products: